UltraGreen.ai Limited Gains Singapore Nod for Verdye, Boosting Southeast Asia Growth

SGX Filings
05/05

UltraGreen.ai Limited (ULG) said on May, 5 2026 that it has received regulatory approval in Singapore for Verdye, its indocyanine green injection used in fluorescence-guided surgery.

The green light in Singapore, a key medical hub for the region, supports the company’s strategy to expand access to fluorescence-guided procedures across Southeast Asia. Verdye is now cleared in 41 countries.

With the approval, UltraGreen.ai plans to deepen collaborations with Singaporean healthcare institutions and accelerate commercial rollout of its integrated platform, which combines pharmaceutical agents, imaging hardware and AI-based data tools.

The company noted that its IC-Flow imaging system is authorised in 45 markets worldwide. The latest milestone follows its recent initial public offering and Verdye’s clearance in the Philippines.

UltraGreen.ai, headquartered in Singapore with operations in the United States, Ireland and other Asia-Pacific locations, develops fluorescence imaging solutions aimed at enhancing surgical precision. For additional details, visit the company’s website.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10